Skip to content

Meghan Joy Smith, M.D. FRCSC

NPI 1144911306ActiveIndividual· Ophthalmology, Uveitis and Ocular Inflammatory Disease· Chicago, IL

Ophthalmology, Uveitis and Ocular Inflammatory Disease (M.D. FRCSC) in Chicago, Illinois, licensed in IL, with an NPI issued in May 2023. Part D covered 56 prescriptions written in 2024, 64% of them generic. Hoffmann-La Roche Limited reported $971.24 in payments in 2025, mostly consulting fees.

Overview

NPI1144911306
StatusActive
Entity typeIndividual
CredentialM.D. FRCSC
Sole proprietorNo
NPI issuedMay 18, 2023
Last updated in NPPESApr 10, 2024
Certified by providerApr 10, 2024
ReactivatedJan 10, 2024

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)56 · 95 30-day fills
Patients23
Total drug cost$49,530
Generic share64% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$971.24 · 2 payments from 1 company
  • 2024$378.22 · 4 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Hoffmann-La Roche Limited$971.242

What the 2025 payments were for

  • Consulting Fee$866.93 · 1 payment
  • Food and Beverage$104.31 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Ophthalmology, Uveitis and Ocular Inflammatory Disease providers in Chicago

All Ophthalmology, Uveitis and Ocular Inflammatory Disease providers in Illinois →